SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | 25-NSE |
25-NSE |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Post-effective amendment to an S-8 filing |
S-8 POS |
Registration Statements
|
Eidos Therapeutics, Inc. | |
| View HTML | Post-effective amendment to an S-Type filing |
POS AM |
Registration Statements
|
Eidos Therapeutics, Inc. | |
| View HTML | Post-effective amendment to an S-8 filing |
S-8 POS |
Registration Statements
|
Eidos Therapeutics, Inc. | |
| View HTML | Post-effective amendment to an S-8 filing |
S-8 POS |
Registration Statements
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. |
Displaying 11 - 20 of 238 results
Data provided by Kaleidoscope.